Day

August 31, 2023

A Wake Up Call about Obviousness-type Double Patenting – the Effect of In re Cellect

What many seem to have understood from Gilead Sciences, Inc. v. Natco Pharma Limited (Fed. Cir. 2014), has been clearly set forth in the recent...

Categories

MWZB Newsletter Signup

Subscribe